TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma
Pathologica · 2024
DOI: 10.32074/1591-951x-937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathologica, 2024. Verfasst von Matteo Brunelli und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Public Health, University of Verona, Italy. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
The surface protein TROP-2/TACSTD2 and the cell adhesion protein NECTIN-4/NECTIN4 are responsible for the efficacy of anticancer therapies based on antibody-drug conjugates (ADC) targeting intracellular microtubules. In contrast with common histologic subtypes of bladder urothelial carcinoma (BUC), little is known of TROP-2 and NECTIN-4 expression in sarcomatoid and rhabdoid BUC.
Aims
In this study, we aimed to analyze TROP-2 and NECTIN-4 expression and additional predictive biomarkers by immunohistochemistry and fluorescence in situ hybridization (FISH) on 35 undifferentiated BUC (28 sarcomatoid and 7 rhabdoid). Wide genomic investigation was also performed on 411 BUC cases of the PanCancer Atlas, focusing on genes related to the microtubule pathways.
Results
Seven of 35 (20%) undifferentiated BUC showed expression of TROP-2. NECTIN-4 was expressed in 10 cases (29%). Seven cases (20%) co-expressed TROP-2 and NECTIN-4. HER-2 FISH was amplified in 5 cases (14%) while HER-2 immunoexpression was observed in 14 cases (40%). PD-L1 scored positive for combined proportion score (CPS) in 66% of cases and for tumor proportion score (TPS) in 51% of cases. Pan-NTRK1-2/3 was elevated in 9 cases (26%) and FGFR-2/3 was broken in 7 of 35 cases (20%). Of 28 sarcomatoid BUC, 9 (32%) were negative for all (TROP-2, NECTIN-4, PD-L1, HER-2, FGFR and pan-NTRK) biomarkers and 3 (11%) expressed all five biomarkers. Among cases with rhabdoid dedifferentiation, 1 of 7 (14%) showed activation of all biomarkers, whereas 2 of 7 (28%) showed none. The mRNA analysis identified microtubule-related genes and pathways suitable for combined ADC treatments in BUC.
Conclusion
Sarcomatoid and rhabdoid BUC do harbor positive expression of the ADC targets TROP-2 or NECTIN-4 in a relatively modest subset of cases, whereas the majority do not. Different combinations of other positive biomarkers may help the choice of medical therapies. Overall, these findings have important clinical implications for targeted therapy for BUC. Read the full article
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostics and Public Health, University of Verona, Italy.
- Department of Translational Medicine, University of Ferrara, Italy.
- Department of Human Sciences for the Promotion of the Quality of Life, San Raffaele Roma Open University, Rome, Italy.
- Medical and Translational Oncology, Department of Oncology, Azienda Ospedaliera S. Maria, Terni, Italy.
- Department of Molecular and Translational Medicine, University of Brescia, Italy.
- Pathology Unit, Azienda Ospedaliera S. Maria, Terni, Italy.
Zitieren
APA
Brunelli, M., Gobbo, S., Malpeli, G., Sirgiovanni, G., Caserta, C., Munari, E., Francesconi, S., Caliò, A., Martignoni, G., Cimadamore, A., Veccia, A., Antonelli, A., Tucci, M., Pierconti, F., Hattab, I. M., Eccher, A., Ascani, S., Milella, M., Buffoni, L., …, & Bracarda, S. (2024). TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma. Pathologica. https://doi.org/10.32074/1591-951x-937
Vancouver
Brunelli M, Gobbo S, Malpeli G, Sirgiovanni G, Caserta C, Munari E, et al. TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma. Pathologica. 2024. doi:10.32074/1591-951x-937
BibTeX
@article{Brunelli2024,
author = {Brunelli, Matteo and Gobbo, Stefano and Malpeli, Giorgio and Sirgiovanni, Grazia and Caserta, Claudia and Munari, Enrico and Francesconi, Simona and Caliò, Anna and Martignoni, Guido and Cimadamore, Alessia and Veccia, Alessandro and Antonelli, Alessandro and Tucci, Marcello and Pierconti, Francesco and Hattab, Isabelle Malak and Eccher, Albino and Ascani, Stefano and Milella, Michele and Buffoni, Lucio and Cheng, Liang and Bracarda, Sergio},
title = {TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma},
journal = {Pathologica},
year = {2024},
doi = {10.32074/1591-951x-937}
}
EUVIMED